Status:
COMPLETED
Heart Function and Exercise Capacity in Patients With Hypertrophic Cardiomyopathy
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Angina, Unstable
Myocardial Infarction
Eligibility:
All Genders
20-75 years
Brief Summary
This study will examine the relationship between certain measures of heart function and exercise capacity in patients with hypertrophic cardiomyopathy (HCM). Patients who participated in NHLBI studie...
Detailed Description
NIH Protocols 01-H-0066, Double Blind Placebo Controlled Study of Pirfenidone A Novel Anti-Fibrotic Drug in Symptomatic patients with Hypertrophic Cardiomyopathy (HCM) Associated with left Ventricular...
Eligibility Criteria
Inclusion
- Eligibility criteria not listed; Analysis of data from previous studies.
Exclusion
Key Trial Info
Start Date :
May 27 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 22 2013
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT00354328
Start Date
May 27 2005
End Date
October 22 2013
Last Update
October 5 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892